Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Doris B Strader"'
Publikováno v:
Journal of Viral Hepatitis. 26:778-781
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4a2b09b8b462b9540aa0968a7b2d1fe
https://doi.org/10.1111/jvh.13083
https://doi.org/10.1111/jvh.13083
Autor:
Leonard B. Seeff, Doris B. Strader
Publikováno v:
Clinical Liver Disease. 1:6-11
Watch the interview with the authors Watch the video presentation of this article Answer questions and earn CME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90dd51d4c83046cb716a7d9190ac392c
https://doi.org/10.1002/cld.1
https://doi.org/10.1002/cld.1
Publikováno v:
Hepatology. 54:1433-1444
The standard of care (SOC) therapy for patients with chronic hepatitis C virus (HCV) infection has been the use of both peginterferon (PegIFN) and ribavirin (RBV). These drugs are administered for either 48 weeks (HCV genotypes 1, 4, 5, and 6) or for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eca2d30467ebdc8321b84d90fb7508c4
https://doi.org/10.1002/hep.24641
https://doi.org/10.1002/hep.24641
Autor:
Peter L. Moses, Lisa M. Glass, Neil Hyman, Meagan Costedio, Elice M. Brooks, Hagen Blaszyk, Matthew Coates, Gary M. Mawe, Michael J. Wood, Doris B. Strader, Allison L Ciolino, Eric K. Ganguly
Publikováno v:
American Journal of Gastroenterology. 105:1173-1180
Changes in mucosal serotonin (5-HT) signaling have been detected in a number of functional and inflammatory disorders of the gastrointestinal (GI) tract. This study was undertaken to determine whether chronic constipation (CC) is associated with diso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6364cc8d5b871ba40a2734f3cd9f98f9
https://doi.org/10.1038/ajg.2009.683
https://doi.org/10.1038/ajg.2009.683
Autor:
Joseph R. Pisegna, Vitaly A. Fishbeyn, Jeffrey A. Norton, Richard V. Benya, Robert T. Jensen, David C. Metz, Murray Orbuch, Doris B. Strader
Publikováno v:
Alimentary Pharmacology & Therapeutics. 7:247-257
SUMMARY A long-term cure is now possible in more than 30% of selected patients with Zollinger–Ellison syndrome who undergo gastrinoma resection. The need, however, for continued gastric acid antisecretory therapy in these patients remains controver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594d0a9a79fd23d72370f8193e03e9a6
https://doi.org/10.1111/j.1365-2036.1993.tb00095.x
https://doi.org/10.1111/j.1365-2036.1993.tb00095.x
Autor:
Robert T. Jensen, Murray Orbuch, Kathryn Feigenbaum, David C. Metz, Doris B. Strader, Pamela D. Koviack
Publikováno v:
Alimentary Pharmacology & Therapeutics. 7:597-610
H+, K(+)-ATPase inhibitors such as omeprazole are the antisecretory agents of choice for the management of gastric acid hypersecretory states, including the Zollinger-Ellison syndrome. However, long-term follow-up data on the overall efficacy and saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b3f0d1c14dee9298fbede8cf4544aa
https://doi.org/10.1111/j.1365-2036.1993.tb00140.x
https://doi.org/10.1111/j.1365-2036.1993.tb00140.x
Autor:
Zachary Goodman, Leonard B. Seeff, Elizabeth C. Wright, Zelma J. Buskell, Matthew M Yeh, Doris B. Strader
Publikováno v:
Journal of Clinical Gastroenterology. 39:722-727
Objective: Histologic liver injury is reported to be less severe in persons who acquire hepatitis C through injection drug use (IDU) than by blood transfusion. Because age correlates with histologic severity, it may be that differences between routes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::919d6e09cfe460c667f3ec117ad9d9fc
https://doi.org/10.1097/01.mcg.0000173852.70419.21
https://doi.org/10.1097/01.mcg.0000173852.70419.21
Autor:
Timothy R. Morgan, Marcos C. Pedrosa, Lennox J. Jeffers, Ramsey Cheung, Hui Shen, Doris B. Strader, Sue Currie, Edmund J. Bini, Warren N. Schmidt, Paul R. King, Richard H. Moseley, B Anand, Charles L. Mendenhall, Norbert Bräu, Kyong-Mi Chang, Stephen J. Rossi, Ayse Aytaman, Anna W. Sasaki, Curt H. Hagedorn, Franz Simon, Teresa L. Wright, Samuel B. Ho, Joseph A. Awad, Ke-Qin Hu, Jawad Ahmad, David W. Johnson, Bradford Waters
Publikováno v:
The American Journal of Gastroenterology. 100:1772-1779
Many veterans may not be candidates for hepatitis C virus (HCV) treatment due to contraindications to therapy. The aims of this study were to determine the proportion of HCV-infected veterans who were eligible for interferon alfa and ribavirin therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca4e9c19bb579f1571169e1b569f681
https://doi.org/10.1111/j.1572-0241.2005.41860.x
https://doi.org/10.1111/j.1572-0241.2005.41860.x